fbpx

U.S. Anti-Doping Agency (USADA)

Global DRO logo in whiteSearch Medications & Ingredients

Wrestling Athlete Vladyslav Dombrovskiy Accepts Sanction for Anti-Doping Rule Violation

two wrestlers in the middle of a matchUSADA announced today that Vladyslav Dombrovskiy, of Colorado Springs, Colo. an athlete in the sport of wrestling, has accepted a four-year suspension for a violation involving his possession and use or attempted use of prohibited substances and his refusal to provide a urine sample.

Dombrovskiy, 30, refused to provide a sample as requested by a USADA doping control officer during an out-of-competition test on March 12, 2020. Evading sample collection or refusing or failing to submit to sample collection without compelling justification is an anti-doping rule violation under the USADA Protocol for Olympic and Paralympic Movement Testing, the United States Olympic and Paralympic Committee National Anti-Doping Policy, and the United World Wrestling Anti-Doping Rules, all of which have adopted the World Anti-Doping Code and the World Anti-Doping Agency Prohibited List.

During an investigation, USADA also obtained specific and credible evidence that Dombrovskiy possessed letrozole in 2019, purchased a product containing GW1516 from an online store in January 2020, and used tamoxifen in February 2020, which he received from a friend. Letrozole and tamoxifen are Specified Substances and GW1516 is a Non-Specified Substance in the category of Hormone and Metabolic Modulators. These substances are prohibited at all times under the above-referenced rules.

Dombrovskiy’s four-year period of ineligibility began on March 10, 2020, the date he admitted using prohibited substances. In addition, Dombrovskiy has been disqualified from competitive results obtained on and subsequent to July 1, 2019, the approximate date on which he first possessed a prohibited substance, including forfeiture of any medals, points and prizes.

In an effort to aid athletes, as well as support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements (www.Supplement411.org) as well as performance-enhancing and recreational drugs. In addition, USADA manages a drug reference hotline, Global Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and distributes a multitude of educational materials, such as an easy-reference wallet card with examples of prohibited and permitted substances, a supplement guide, a nutrition guide, an athlete handbook, and periodic alerts and advisories.

Along with education and testing, robust anti-doping programs enable investigations stemming from tips and whistleblowers. USADA makes available a number of ways to report the abuse of performance-enhancing drugs in sport in an effort to protect clean athletes and promote clean competition. Any tip can be reported using the USADA Play Clean Tip Center, by email at playclean@usada.org, by phone at 1-877-Play Clean (1-877-752-9253) or by mail.

USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.


For more information or media inquiries, click here.

Scroll to Top